此服务在您所在的地区不可用。

A B CAPITALS LLC

印度

成立于

2021 (5 年)

成立

最后在线: 最近无活动

访问网站

暂无 TrustScore分数不足，无法显示趋势。

成为首个为该公司评分和评论的用户。

综合得分

牌照

--/40

--/60

0 条评价

由 TrustFinance 提供

暂无 TrustScore分数不足，无法显示趋势。

成为首个为该公司评分和评论的用户。

受监管的

IUX

(2,283 评论)

Mauritius

2016

(10 年)

安全信息 :

FSCA

FSC

ASIC

安全信息

警告

该公司目前未经证实.

请注意潜在风险！

牌照

甲級牌照

由全球知名监管机构颁发，这些许可证通过严格的合规性、资金隔离、保险和定期审计，确保最高程度的交易者保护。争议解决和遵守 AML/CTF 标准进一步提高了安全性。

B 級牌照

由受尊敬的区域监管机构授予，这些许可证提供强大的安全措施，例如资金隔离、财务报告和补偿计划。虽然没有等级 1 那么严格，但它们提供可靠的区域保护。

C 級牌照

由新兴市场的监管机构颁发，这些许可证提供基本保护，例如最低资本要求和 AML 政策。监管较不严格，因此交易者应谨慎行事并验证安全措施。

D 級牌照

来自监管最少的司法管辖区，这些许可证通常缺乏关键保护，例如资金隔离和保险。虽然它们对运营弹性很有吸引力，但它们对交易者构成较高的风险。

公司資料

了解 A B CAPITALS LLC

公司資料

了解 A B CAPITALS LLC

A B CAPITALS LLC positions itself as a global brokerage founded by financial professionals aiming to provide a transparent, secure, and efficient trading environment. The company emphasizes its use of modern technology to offer clients competitive trading conditions, including low spreads, fast execution, and access to a diverse portfolio of over 1000 tradable assets. It operates through popular trading platforms and is registered in St. Vincent and the Grenadines.

行业

外汇零售经纪人主要
金融其他服务

软件

没有可用的数据

看起来这个部分是空的。请尽快回来获取更新！

联络

社交

公司尚未更新其信息。

A B CAPITALS LLC 评论

总计 0

排序依据

过滤器

公司資料

了解 A B CAPITALS LLC

公司資料

了解 A B CAPITALS LLC

A B CAPITALS LLC positions itself as a global brokerage founded by financial professionals aiming to provide a transparent, secure, and efficient trading environment. The company emphasizes its use of modern technology to offer clients competitive trading conditions, including low spreads, fast execution, and access to a diverse portfolio of over 1000 tradable assets. It operates through popular trading platforms and is registered in St. Vincent and the Grenadines.

行业

外汇零售经纪人主要
金融其他服务

软件

没有可用的数据

看起来这个部分是空的。请尽快回来获取更新！

联络

社交

公司尚未更新其信息。

新聞

TrustFinance 情報機構

研究日期: 4月 28, 2026

Brokerages have provided their outlook on major Indian companies, showing optimism for Larsen & Toubro (L&T) and Aditya Birla Capital, while being cautious about Sun Pharmaceutical Industries. L&T has a 'buy' rating but a lowered target price due to regional tensions affecting its order book. Aditya Birla Capital is experiencing strong growth in lending, particularly in the MSME sector. In contrast, Goldman Sachs maintains a 'sell' rating on Sun Pharma, highlighting its innovative medicines as a growth driver but noting minimal exposure to West Asia. Other companies discussed include Bajaj Finance and Havells India, with varying ratings based on their market performance and future prospects.

Brokerages have provided their outlook on major Indian companies, showing optimism for Larsen & Toubro (L&T) and Aditya Birla Capital, while being cautious about Sun Pharmaceutical Industries. L&T has a 'buy' rating but a lowered target price due to regional tensions affecting its order book. Aditya Birla Capital is experiencing strong growth in lending, particularly in the MSME sector. In contrast, Goldman Sachs maintains a 'sell' rating on Sun Pharma, highlighting its innovative medicines as a growth driver but noting minimal exposure to West Asia. Other companies discussed include Bajaj Finance and Havells India, with varying ratings based on their market performance and future prospects.

The MSCI February 2026 index review has added Aditya Birla Capital and L&T Finance to the Global Standard Index, while removing IRCTC. India's overall weight remains at 14.1% with 165 companies listed. The Small Cap Index saw a reduction in Indian companies from 508 to 480, with several stocks being added and removed. Estimated fund flows suggest significant inflows for Aditya Birla Capital and L&T Finance, while IRCTC may experience outflows due to its removal from the index.

The MSCI February 2026 index review has added Aditya Birla Capital and L&T Finance to the Global Standard Index, while removing IRCTC. India's overall weight remains at 14.1% with 165 companies listed. The Small Cap Index saw a reduction in Indian companies from 508 to 480, with several stocks being added and removed. Estimated fund flows suggest significant inflows for Aditya Birla Capital and L&T Finance, while IRCTC may experience outflows due to its removal from the index.

由TrustFinance AI分析提供

新聞

TrustFinance 情報機構

研究日期: 4月 28, 2026

Brokerages have provided their outlook on major Indian companies, showing optimism for Larsen & Toubro (L&T) and Aditya Birla Capital, while being cautious about Sun Pharmaceutical Industries. L&T has a 'buy' rating but a lowered target price due to regional tensions affecting its order book. Aditya Birla Capital is experiencing strong growth in lending, particularly in the MSME sector. In contrast, Goldman Sachs maintains a 'sell' rating on Sun Pharma, highlighting its innovative medicines as a growth driver but noting minimal exposure to West Asia. Other companies discussed include Bajaj Finance and Havells India, with varying ratings based on their market performance and future prospects.

The MSCI February 2026 index review has added Aditya Birla Capital and L&T Finance to the Global Standard Index, while removing IRCTC. India's overall weight remains at 14.1% with 165 companies listed. The Small Cap Index saw a reduction in Indian companies from 508 to 480, with several stocks being added and removed. Estimated fund flows suggest significant inflows for Aditya Birla Capital and L&T Finance, while IRCTC may experience outflows due to its removal from the index.

由TrustFinance AI分析提供

A B CAPITALS LLC

IUX

公司資料

公司資料

评论

A B CAPITALS LLC 评论

评论

总计 0

A B CAPITALS LLC

IUX

公司資料

公司資料

睇A B CAPITALS LLC嘅用戶仲睇…

IUX

XM

FXGT

Deriv

Exness

IUX

XM

FXGT

Deriv

Exness

新聞

TrustFinance 情報機構

评论

A B CAPITALS LLC 评论

评论

总计 0

睇A B CAPITALS LLC嘅用戶仲睇…

IUX

XM

FXGT

Deriv

Exness

IUX

XM

FXGT

Deriv

Exness

新聞

TrustFinance 情報機構